[EN] HALOALLYLAMINE PYRAZOLE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF [FR] INHIBITEURS DE LYSYL OXYDASES DÉRIVÉS D'HALOGÉNOALLYLAMINE PYRAZOLE ET LEURS UTILISATIONS
[EN] HALOALLYLAMINE PYRAZOLE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF [FR] INHIBITEURS DE LYSYL OXYDASES DÉRIVÉS D'HALOGÉNOALLYLAMINE PYRAZOLE ET LEURS UTILISATIONS
There is provided a compound of Formula I
1
wherein each T is independently selected from H, hydrocarbyl, —F—R, and a bond with one of D, E, P or Q, or together with one of P and Q forms a ring; Z is a suitable atom the valency of which is m; D, E and F are each independently of each other an optional linker group, wherein when Z is nitrogen E is other than CH
2
and C═O; P, Q and R are independently of each other a ring system; and at least Q comprises a sulphamate group.
[EN] 1,2,4-TRIAZOLE DERIVATIVES CONTAINING A SULPHAMATE GROUP AS AROMATASE INHIBITORS<br/>[FR] DERIVES 1,2,4-TRIAZOLE CONTENANT UN GROUPE SULFAMATE EN TANT QU'INHIBITEURS D'AROMATASE
申请人:STERIX LTD
公开号:WO2003045925A1
公开(公告)日:2003-06-05
There is provided a compound of Formula (I), wherein each T is independently selected from H, hydrocarbyl, -F-R, and a bond with one of D, E, P or Q, or together with one of P and Q forms a ring; Z is a suitable atom the valency of which is m; D, E and F are each independently of each other an optional linker group, wherein when Z is nitrogen E is other than CH2 and C=O; P, Q and R are independently of each other a ring system; and at least Q comprises a sulphamate group.
1,2,4-TRIAZOLE DERIVATIVES CONTAINING A SULPHAMATE GROUP AS AROMATASE INHIBITORS
申请人:Sterix Limited
公开号:EP1446388B1
公开(公告)日:2013-01-09
HALOALLYLAMINE PYRAZOLE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF
申请人:Pharmaxis Ltd.
公开号:US20200069648A1
公开(公告)日:2020-03-05
The present invention relates to novel compounds which are capable of inhibiting certain amine oxidase enzymes. These compounds are useful for treatment of a variety of indications, e.g., fibrosis, cancer and/or angiogenesis in human subjects as well as in pets and livestock. In addition, the present invention relates to pharmaceutical compositions containing these compounds, as well as various uses thereof.